February 26, 2013
All Blue Cross and Blue Shield of Kansas Contracting ProvidersFrom:
Connie Winkley – Education/Communication Coordinator
Institutional Provider Relations
Blue Cross and Blue Shield of Kansas, Inc.
An Independent Licensee of the Blue Cross and Blue Shield Association
DeNovo NT Natural Tissue Graft by Zimmer
Blue Cross and Blue Shield of Kansas (BCBSKS) considers the DeNovo NT Natural Tissue Graft by Zimmer to be considered experimental/ /investigational (E/I).
This determination was reached based on the following:
The DeNovo NT Graft Natural Tissue Graft is currently in a Clinical Trial and is considered E/I. BCBSKS recommends that the provider submits a signed Limited Patient Waiver (LPW) by the member if services, which are considered E/I, are provided to the member.
BCBSKS recommends providers review two medical policies when performing this service. These policies include the Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions and Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions. Click on the link to view the details of each medical policy.
If you have questions regarding this newsletter, please contact your BCBSKS Provider Representative.